Aerodigm Wealth LLC Investment Activity Analysis: Q3 Insights

Aerodigm Wealth LLC saw its total portfolio value reach $295.5 million as of June 30th, 2026.

Purchase Activity This Quarter

During the third quarter, Aerodigm Wealth demonstrated active buying in several sectors and specific ETFs. Notably, Dimensional Fund Advisors' Dimensional Neuroimmune Therapeutics ETF (DFNM) experienced a substantial increase of 298.97%, suggesting it was either newly added or significantly increased during this period.

Furthermore, Vanguard's offerings showed strong interest with the Vanguard Tax-Managed Dividend Growth ETF (VGIT) increasing by 4.24% and the Vanguard Small Cap Index Fund Institutional Shares (AVDV) also seeing a healthy rise of 5.42%. iShares Technology ETF (ITOT) maintained its position, growing by 3.73%, while iShares Core Dividend Growth ETF (IDEV) added another 2.64%.

Significant additions were also made to other Dimensional funds: the Dimensional Fund Advisors Natural Resources ETF (DFIC) increased by -10.83%? Wait, that doesn't make sense for a purchase. Let's recheck. Actually, looking at DFNM, it was the standout purchase with such a large increase.

Sale and Reduction Activity This Quarter

Conversely, Aerodigm Wealth also saw notable reductions or exits from certain holdings during Q3. The most significant departure appears to be AbSci Corporation (ABSI), which experienced an 8.92% decrease in shares? Wait, the change_percent_from_prior_period is -53.05%, and change_in_shares_from_prior_period is -70000. This indicates a substantial reduction or exit from ABSI.

Additionally, Vanguard's Technology Shares ETF (VEA) saw its position decrease by 1.93%. Dimensional Fund Advisors' Dimensional Emerging Markets Income ETF (DFEM) and Dimensional Fund Advisors Small Cap Value ETF (BSVO) also showed reductions of 0.96% and 1.83% respectively.

Overall Portfolio Changes

The portfolio's holdings count increased to 89, indicating a more diversified position compared to the previous period. The top five holdings accounted for approximately 37.72% of the total value as of June 30th.

Sector Allocations

As of June 30th, Aerodigm Wealth's portfolio was dominated by 'Unknown' sector holdings (90.44%), followed closely by Technology (3.92%) and Consumer Cyclical (1.43%). Smaller allocations were present in sectors like Consumer Defensive (1.37%), Financial Services (1.32%), Healthcare (0.65%), Communication Services (0.48%), Energy (0.24%), Industrials (0.08%), Real Estate (0.07%), and a very small portion remained unallocated.

Conclusion

Aerodigm Wealth's portfolio saw significant shifts in Q3 2026, characterized by substantial buying activity, particularly in Dimensional Neuroimmune Therapeutics ETF (DFNM) and Vanguard Small Cap Index Fund Institutional Shares (VGIT), alongside notable reductions or exits from positions like AbSci Corporation (ABSI). The overall allocation remains heavily weighted towards 'Unknown' holdings, with Technology being the largest disclosed sector. For more detailed information on Aerodigm Wealth's portfolio composition and performance, please visit Aerodigm Wealth.